Allurion TechnologiesALURD -2.11%16 Gross Margin % is 41.70% as of Mar. 2026, which is 45% below its 10-year median of 76.33. GuruFocus rates ALURD with a GF Score™ of 16/100 and a GF Value™ of $10.66 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Allurion Technologies ranks better than 51.06% on this metric.
ALURD's Gross Margin % is ranked better than 51.06% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs ALURD: 52.70
Allurion Technologies had a gross margin of 41.70% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Allurion Technologies was 0.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Allurion Technologies had a gross margin of 41.70% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Allurion Technologies Gross Margin % Related Terms
Allurion Technologies Gross Margin % Historical Data
* Premium members only.
The historical data trend for Allurion Technologies's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ALURD vs ALRTF, VVOS, SINT: Gross Margin % Comparison
For the Medical Devices subindustry, Allurion Technologies's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Allurion Technologies Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Allurion Technologies's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Allurion Technologies's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Allurion Technologies (ALURD) has a Gross Margin % of 41.70% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Allurion Technologies and its competitors. This is 45% below median its historical median of 76.33. Over the past decade, Allurion Technologies' Gross Margin % has ranged from 52.70 to 79.00. According to the industry distribution chart, Allurion Technologies ranks #394 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 48.9%.
Is Allurion Technologies' Gross Margin % too high?
Allurion Technologies' current Gross Margin % of 41.70% is 45% below median its 10-year median of 76.33. Over the past 10 years, this metric has ranged from a low of 52.70 to a high of 79.00. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Allurion Technologies' value of 41.70% is 19.9% below this industry median. Based on the distribution chart, Allurion Technologies ranks #394 out of 805 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Allurion Technologies has a GF Score™ of 16/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Allurion Technologies' Gross Margin % compare to ALRTF and VVOS?
According to the Medical Devices & Instruments industry distribution chart, Allurion Technologies ranks #394 out of 805 companies for Gross Margin %. This puts Allurion Technologies in the upper half of its industry. The industry median Gross Margin % is 52.07. Allurion Technologies' value of 41.70% is 19.9% below this benchmark. Historically, Allurion Technologies' own Gross Margin % has ranged from 52.70 to 79.00 over the past decade. While the company's 10-year median is 76.33 vs. the industry median of 52.07, Allurion Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Allurion Technologies's current Gross Margin % of 41.70% is 19.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Allurion Technologies and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Allurion Technologies's current Gross Margin % is 41.70%, which is 45% below median its own 10-year median of 76.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Allurion Technologies stock overvalued right now?
Based on GuruFocus' analysis, Allurion Technologies (ALURD) is currently considered Possible Value Trap. The stock's GF Value™ is $10.66, compared to a current price of $5.91 — trading 44.6% below its estimated fair value. The current Gross Margin % is 41.70%, which is 45% below median its 10-year median of 76.33 and 19.9% below the Medical Devices & Instruments industry median of 52.07. Allurion Technologies' overall GF Score™ is 16/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Allurion Technologies (ALURD), the current Gross Margin % is 41.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Allurion Technologies (ALURD) Overvalued in 2026?
Based on GuruFocus' analysis, Allurion Technologies stock appears to be undervalued.
The current stock price of $5.91 is trading 44.6% below its estimated GF Value™ of $10.66.
GuruFocus considers Allurion Technologies to be Possible Value Trap.
Key valuation signals for ALURD:
Gross Margin %: 41.70% (45% below median its 10-year median of 76.33)
GF Value™: $10.66 vs. price of $5.91 (44.6% below fair value)
Industry Position: 19.9% below the Medical Devices & Instruments median (#394 of 805)
No single metric tells the full story. See the ALURD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
16GF Score
Get the complete analysis for ALURD
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALURD has been successfully added to your 
